Centene Corp. lands RBC coverage, shares trade near 52-week high on NYSE
Published on 06/23/2026 at 16:57 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWSBy Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 16:56.
Centene Corp. (US15133V1035) is back on Wall Street’s radar after RBC Capital Markets initiated coverage, while the managed care group’s shares continue to trade close to a 52-week high on the NYSE. RBC starts with a Sector Perform rating and a $70 price target, according to an Investing.com summary of the RBC note.
RBC’s view on valuation and recovery
RBC Capital Markets describes Centene as entering 2026 with early signs of recovery after what the analysts call a challenging 2025, with Medicaid margins expected to normalize as state rate actions catch up with medical cost trends. The firm’s $70 price objective implies moderate upside versus the low-to-mid 60s trading range, but RBC argues the stock is “appropriately priced” after a strong run.
According to the RBC note, Centene’s shares have delivered around a 60 percent total return over the past six months and are trading near a 52-week high of about $66.55, underlining the marked re-rating of U.S. managed care peers such as UnitedHealth and Elevance in the same period.
What other analysts are saying
Centene’s analyst backdrop has turned more constructive in recent weeks, with Deutsche Bank upgrading the stock from Hold to Buy and lifting its price target to $80 on expectations of an earnings recovery into the 2028 horizon. MarketScreener aggregates the average target price for Centene at just over $61 per share, reflecting a mix of Neutral and Buy stances across the U.S. coverage universe.
On earnings expectations, MarketBeat data show consensus for Centene’s current-year earnings per share modestly above prior-year levels, with the next quarterly update scheduled later in the year and investors watching Medicaid redetermination effects and Marketplace margins closely.
Background and price data on Centene Corp.
All current news, key figures and historical price moves on the Centene Corp. shares can be found in the dedicated topic section and on the company’s own investor pages.
How Centene makes its money
Centene’s core business is government-sponsored health coverage, with a focus on Medicaid managed care, Medicare Advantage and Affordable Care Act Marketplace plans in the United States. The company administers benefits for state and federal programs, taking on medical cost risk in exchange for fixed per-member-per-month premiums.
Where the Centene shares trade today
The Centene Corp. shares (US15133V1035) last closed on the NYSE at 63.68 US dollars on 2026-06-22, 15:59 Eastern Time, according to MarketBeat data.
Centene Corp. at a glance
- Company: Centene Corp.
- ISIN: US15133V1035
- WKN: A1439V
- Ticker: CNC
- Trading venue: NYSE
- Price (as of 2026-06-22, 15:59): 63.68 USD
- Market cap: 34.6 billion USD (as of 2026-06-22)
- Sector / industry: Health Care / Managed Care
- Index membership: S&P 500
- Next earnings date: 2026-07-23
This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or any other kind of financial service. All data have been researched carefully but without any guarantee of completeness or accuracy. Investors should conduct their own research or consult a professional adviser before making investment decisions.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
